Discover 1,280 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,280
Active & Responsive
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Location: Phoenix AZ, San Diego CA, Los Angeles CA,
Sponsor: Mezzion Pharma Co. Ltd
Sex: All
Age: 12 - 18
Code: NCT05918211
Phase3, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Phoenix AZ, Loma Linda CA, Downey CA, Los Angeles CA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase3, Recruiting
Active & Responsive
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
for
Acute Myeloid Leukemia
Location: Phoenix AZ, Duarte CA, Salt Lake City UT, Stanford CA,
Sponsor: Norman J. Lacayo
Sex: All
Age: 0 - 21
Code: NCT05101551
Phase1, Recruiting
Active & Responsive
Danon Disease Natural History Study
for
Danon Disease
Location: Phoenix AZ, La Jolla CA, Aurora CO, Dallas TX,
Sponsor: Rocket Pharmaceuticals Inc.
Sex: All
Age: 8+
Code: NCT06214507
Recruiting
Active & Responsive
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Phoenix AZ, Los Angeles CA, Aurora CO, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 2+
Code: NCT06789913
Phase2, Recruiting
Active & Responsive
ATSN-201 Gene Therapy in RS1-Associated X-linked Retinoschisis
for
X-linked Retinoschisis
Location: Phoenix AZ, Los Angeles CA, Salt Lake City UT,
Sponsor: Atsena Therapeutics Inc.
Sex: All
Age: 6+
Code: NCT05878860
Phase3, Recruiting
Active & Responsive
Study of ALK-001 on the Progression of Stargardt Disease
for
Stargardt Disease
Location: Phoenix AZ, Aurora CO, San Antonio TX, Fort Worth TX,
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All
Age: 8 - 45
Code: NCT07419334
Phase3, Recruiting
Active & Responsive
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension